Filing Details
- Accession Number:
- 0001209191-17-042554
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-30 16:50:19
- Reporting Period:
- 2017-06-28
- Filing Date:
- 2017-06-30
- Accepted Time:
- 2017-06-30 16:50:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1524472 | Xylem Inc. | XYL | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1226924 | R Steven Loranger | 1 International Drive C/O Xylem Inc. Rye Brook NY 10573 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-06-28 | 56,199 | $30.03 | 65,030 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-06-28 | 56,199 | $55.00 | 8,831 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-06-29 | 9,933 | $30.03 | 18,764 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-06-29 | 9,933 | $55.05 | 8,831 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2017-06-28 | 56,199 | $0.00 | 56,199 | $30.03 |
| Common Stock | Stock option (right to buy) | Disposition | 2017-06-29 | 9,933 | $0.00 | 9,933 | $30.03 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 9,933 | 2018-10-31 | No | 4 | M | Direct | |
| 0 | 2018-10-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 130,918 | Indirect | By Steven R. Loranger Revocable Trust |
Footnotes
- The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on June 1, 2016.
- This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $55.00 to $55.02 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
- This price represents the approximate weighted average price per Share of the Issuer that were executed at prices ranging from $55.00 to $55.30 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
- These options are fully vested and exercisable.
Billionaire Hedge Funds
